Emylcamate

Drugbox
IUPAC_name = 3-methyl-3-pentanol carbamate


width = 162
CAS_number=78-28-4
ATC_prefix=N05
ATC_suffix=BC03
ATC_supplemental=
PubChem=6526
DrugBank=
C=7 | H=15 | N=1 | O=2
molecular_weight =
bioavailability=
metabolism =
elimination_half-life=
excretion =
pregnancy_category =
legal_status =
routes_of_administration=

Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed.

References

* [http://www.revistapsiqrs.org.br/administracao/arquivos/10-698-olhando_para_tras.pdf Olhando para trás: um novo caminho possível para a descoberta de drogas em psicofarmacologia] (Portuguese)
* [http://ctd.mdibl.org/voc.go?voc=chem&termUI=emylcamate The Comparative Toxicogenomics Database: Emylcamate] .
* [http://www.biam2.org/www/Sub2770.html BIAM: Emylcamate] (French).